__NUXT_JSONP__("/drugs/Anti-CD30_Monoclonal_Antibody_XmAb2513", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"A humanized monoclonal antibody directed against the cell surface receptor CD30 with potential immunotherapeutic activity. Anti-CD30 monoclonal antibody XmAb2513 specifically binds to the CD30 antigen, which may result in a cytotoxic T lymphocyte (CTL) response against CD30-expressing tumor cells. CD30, a member of the tumor necrosis factor (TNF) receptor superfamily, is expressed on activated lymphocytes transiently and is constitutively expressed in hematologic malignancies including Hodgkin's disease and some T-cell non-Hodgkin's lymphomas.",fdaUniiCode:"33VWC847G8",identifier:"C74005",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C129822","C164002"],synonyms:[c,"XMAB-2513","XmAb2513"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FAnti-CD30_Monoclonal_Antibody_XmAb2513",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","Anti-CD30_Monoclonal_Antibody_XmAb2513","Anti-CD30 Monoclonal Antibody XmAb2513","2021-10-30T13:44:12.663Z")));